Literature DB >> 7593242

Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system.

L X Xu1, T Kukita, A Kukita, T Otsuka, Y Niho, T Iijima.   

Abstract

Recombinant human interleukin-10 (hIL-10) inhibited the formation of osteoclast-like multinucleated cells in rat whole bone marrow cultures. The effect of hIL-10 on the process of osteoclast formation was further examined, since the process of osteoclast formation includes the proliferation and the differentiation of osteoclast progenitors into mononuclear preosteoclasts and the fusion of preosteoclasts into multinucleated osteoclasts. In the nonadherent bone marrow cell culture system, which was free of stromal cells and formed preosteoclast-like cells, hIL-10 significantly inhibited the formation of preosteoclast-like cells even at a very low concentration (0.5 U/ml). The strong inhibition appeared even after treatment with hIL-10 for only the first 24 h of the culture. However, hIL-10 did not affect the fusion process of preosteoclast-like cells to form osteoclast-like multinucleated cells in the rat coculture system of preosteoclast-like cells with primary osteoblasts. Furthermore, hIL-10 completely inhibited the colony formation induced by granulocyte macrophage colony-stimulating factor (GM-CSF). These findings suggest that the inhibition of osteoclastogenesis by hIL-10 started at the early stage of the differentiation of osteoclast progenitors to preosteoclasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593242     DOI: 10.1002/jcp.1041650321

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Adenosine A2A receptor activation prevents wear particle-induced osteolysis.

Authors:  Aránzazu Mediero; Sally R Frenkel; Tuere Wilder; Wenjie He; Amitabha Mazumder; Bruce N Cronstein
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

2.  Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women.

Authors:  Satish Bharadwaj; Tezus A G Naidu; Guru V Betageri; Nemani V Prasadarao; A Satyanarayan Naidu
Journal:  Inflamm Res       Date:  2010-05-15       Impact factor: 4.575

Review 3.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

4.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

5.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

Authors:  Toshihisa Kawai; Takashi Matsuyama; Yoshitaka Hosokawa; Seicho Makihira; Makoto Seki; Nadeem Y Karimbux; Reginaldo B Goncalves; Paloma Valverde; Serge Dibart; Yi-Ping Li; Leticia A Miranda; Cory W O Ernst; Yuichi Izumi; Martin A Taubman
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.

Authors:  Hiroya Hasegawa; Seisui Kido; Mineko Tomomura; Kengo Fujimoto; Michi Ohi; Masaru Kiyomura; Haruhide Kanegae; Akemi Inaba; Hiroshi Sakagami; Akito Tomomura
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

7.  Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.

Authors:  George D Kalliolias; Baohong Zhao; Antigoni Triantafyllopoulou; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Arthritis Rheum       Date:  2010-02

8.  Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes.

Authors:  Naiomy Deliz Rios-Arce; Jonathan D Schepper; Andrew Dagenais; Laura Schaefer; Connor S Daly-Seiler; Joseph D Gardinier; Robert A Britton; Laura R McCabe; Narayanan Parameswaran
Journal:  Bone       Date:  2020-02-21       Impact factor: 4.398

9.  Modulation of Osteoblastic Cell Efferocytosis by Bone Marrow Macrophages.

Authors:  Megan N Michalski; Amy J Koh; Savannah Weidner; Hernan Roca; Laurie K McCauley
Journal:  J Cell Biochem       Date:  2016-05-05       Impact factor: 4.429

10.  Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs.

Authors:  Byung Jun Jang; Ye Eun Byeon; Ji Hey Lim; Hak Hyun Ryu; Wan Hee Kim; Yoshihisa Koyama; Masanori Kikuchi; Kyung Sun Kang; Oh Kyeong Kweon
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.